Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

In vitro leukemic cell differentiation and WT1 gene expression.

E Hernandez-Caballero1, H Mayani, J J Montesinos

  • 1Human Genetics Research Unit, National Medical Center, IMSS, Apdo. Postal E-014, Coahuila 5, Col Roma, CP 06703, Mexico DF, Mexico.

Leukemia Research
|July 11, 2006
PubMed
Summary

WT1 isoforms expression is higher in acute myelogenous leukemia (AML) cells compared to normal cells. Cytokines like GM-CSF and G-CSF modulate WT1 expression patterns during myeloid differentiation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Definition of severity, management, and follow-up of isolated snoring in adults: An international consensus.

European annals of otorhinolaryngology, head and neck diseases·2026
Same author

Bacterial diversity in high Andean grassland soils disturbed with Lepidium meyenii crops evaluated by metagenomics.

Brazilian journal of biology = Revista brasleira de biologia·2021
Same author

Understanding the hematopoietic microenvironment in chronic myeloid leukemia: A concise review.

Current research in translational medicine·2021
Same author

Surgical treatment of epiglottis collapse in obstructive sleep apnoea syndrome: epiglottis stiffening operation.

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale·2020
Same author

Mesenchymal Stromal Cells from the Epidermis and Dermis of Psoriasis Patients: Morphology, Immunophenotype, Differentiation Patterns, and Regulation of T Cell Proliferation.

Stem cells international·2019
Same author

Prospective multicentre study on barbed reposition pharyngoplasty standing alone or as a part of multilevel surgery for sleep apnoea.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2017

Area of Science:

  • Hematology
  • Molecular Biology
  • Cancer Research

Background:

  • Acute myelogenous leukemia (AML) is a heterogeneous cancer characterized by the abnormal proliferation of myeloid blasts.
  • The Wilms tumor 1 (WT1) gene and its isoforms play critical roles in hematopoietic stem cell differentiation and leukemogenesis.
  • Understanding WT1 expression dynamics is crucial for deciphering AML pathogenesis and developing targeted therapies.

Purpose of the Study:

  • To investigate the expression patterns of four WT1 isoforms in CD34(+) cells from AML patients.
  • To assess the impact of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on WT1 expression and myeloid differentiation in AML.
  • To compare WT1 expression in AML-derived cells with their normal counterparts.

Related Experiment Videos

Main Methods:

  • Primary CD34(+) cells were isolated from AML patients and healthy donors.
  • Cells were cultured in the presence or absence of GM-CSF and G-CSF for 20 days.
  • Expression levels of four WT1 isoforms were analyzed at days 0, 10, and 20 using quantitative methods.
  • Cell differentiation towards the myeloid lineage was assessed.

Main Results:

  • WT1 isoforms expression was consistently higher in AML-derived CD34(+) cell-enriched fractions compared to normal CD34(+) cells.
  • Both normal and AML cells exhibited myeloid lineage differentiation during culture.
  • Distinct WT1 expression patterns were observed during myeloid differentiation in both cell types.
  • The presence of cytokines (GM-CSF and G-CSF) influenced WT1 expression patterns, particularly by day 20.

Conclusions:

  • WT1 expression is elevated in AML CD34(+) cells and exhibits distinct patterns during myeloid differentiation.
  • Cytokines significantly modulate WT1 expression during myeloid differentiation in both normal and AML contexts.
  • These findings highlight the complex role of WT1 in AML and suggest potential therapeutic avenues targeting WT1-cytokine interactions.